Joincare Pharmaceutical Group Industry (600380.SS) Earnings Analysis

Joincare Pharmaceutical Group Industry (600380.SS) next reports earnings on 2026-08-25. It has beaten estimates in 1/3 recent quarters (33%). Trailing P/E 14.52.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 600380.SS next report earnings?

Next earnings date2026-08-25
Consensus EPS estimaten/a
Revenue estimate3.77B

600380.SS earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-240.23 CNYn/an/an/a
2026-04-010.13 CNYn/an/an/a
2025-10-250.1674 CNYn/an/an/a
2025-04-070.23 CNY0.22 CNY+4.5%Beat
2024-10-240.1788 CNY0.19 CNY-5.9%Miss
2024-08-230.1799 CNY0.19 CNY-5.3%Miss

Beat rate: 1/3 (33%) over reported quarters with consensus data.

600380.SS valuation and analyst view

Trailing P/E14.52
Trailing EPS0.71865 CNY
Price / book1.21
Dividend yield2.13%
Market cap19.17B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Joincare Pharmaceutical Group Industry (600380.SS)'s next earnings date?

Joincare Pharmaceutical Group Industry is next scheduled to report on 2026-08-25 and revenue estimate of 3.77B.

Did 600380.SS beat earnings last quarter?

Consensus estimate data was not available for 600380.SS's 2026-04-24 report.

What is 600380.SS's earnings track record?

Over the last 3 reported quarters with consensus data, 600380.SS beat estimates 1 times (33%).

What is 600380.SS's current P/E ratio and EPS?

600380.SS trades at a trailing P/E of 14.52 on trailing EPS of 0.718646691444042 CNY.

What do analysts rate 600380.SS?

600380.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.